30.07.2015

PJSC SIC “Borshchahivskiy CPP” expanded the range of sedative products. A new medicinal product – Valevigran – was added to the Company’s product portfolio. The new product is marketed in a form of capsules (10 capsules per blister, two blisters per box).

Valevigran reduces excitability of the central nervous system, reduces stress and irritability, has sedative, hypnotic and mild antispasmodic effects. The product practically does not inhibit the psychomotor function, and does not reduce workability even in a long-term use. The effects of the product are due to the hydrophilic properties of valerian complex.

Therapeutical indications:
•    nervousness, insomnia;
•    as a combination therapy for treatment of mild functional cardiovascular disorders.
Note: the range of sedative products of PJSC SIC “Borshchahivskiy CPP” also includes the following products: Menovalen, Trivalumen, and Valerica.